Literature DB >> 16931419

Scutellarin protects PC12 cells from oxidative stress-induced apoptosis.

H Hong1, G-Q Liu.   

Abstract

The present study investigated the effects of scutellarin on oxidative stress-induced cell apoptosis in PC12 cells. Exposure of cells to hydrogen peroxide (H2O2) triggered a typical apoptosis, as evidenced by DNA fragmentation, DNA loss and externalization of phosphatidylserine (PS). This treatment also caused significant elevation of oxidative stress characterized by intracellular accumulations of reactive oxygen species (ROS) and malondialdehyde (MDA), a product of lipid peroxidation. Preincubation of cells with scutellarin significantly inhibited the fragmentation and loss of DNA, the externalization of PS, and decreased the percentage of cell apoptosis. Also, intracellular accumulations of ROS and MDA resulting from H2O2 exposure were significantly reduced by scutellarin. These findings suggest that scutellarin exerts significant protection against oxidative stress-induced apoptosis, which might be beneficial for the prevention and treatment of oxidative stress-mediated disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931419     DOI: 10.1080/10286020412331286470a

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  3 in total

1.  Dl-3-n-Butylphthalide improves lipopolysaccharide-induced depressive-like behavior in rats: involvement of Nrf2 and NF-κB pathways.

Authors:  Mengqi Yang; Ruili Dang; Pengfei Xu; Yujin Guo; Wenxiu Han; Dehua Liao; Pei Jiang
Journal:  Psychopharmacology (Berl)       Date:  2018-06-25       Impact factor: 4.530

2.  Scutellarin attenuates hypertension-induced expression of brain Toll-like receptor 4/nuclear factor kappa B.

Authors:  Xingyong Chen; Xiaogeng Shi; Xu Zhang; Huixin Lei; Simei Long; Huanxing Su; Zhong Pei; Ruxun Huang
Journal:  Mediators Inflamm       Date:  2013-09-25       Impact factor: 4.711

3.  Scutellarin Reduces Endothelium Dysfunction through the PKG-I Pathway.

Authors:  Xiaohua Du; Chen Chen; Min Zhang; Donghua Cai; Jiaqi Sun; Jian Yang; Na Hu; Congji Ma; Liyan Zhang; Jun Zhang; Weimin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-19       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.